Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Life Science

• Publication date

  1986-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0024-3205(86)90265-1PMID 3951320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae.

  1983cited by this paper
• Steroid-induced fractures and bone loss in patients with asthma.

  1983cited by this paper
• Detection and characterization of small midregion parathyroid hormone fragment(s) in normal and hyperparathyroid glands and sera by immunoextraction and region-specific radioimmunoassays.

  1981cited by this paper
• Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man.

  1981cited by this paper
• Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.

  1980cited by this paper
• Testicular aromatization in immature rats: localization and stimulation after gonadotropin administration in vivo.

  1979cited by this paper
• Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks: effects of vitamin D3 and 1,25-dihydroxyvitamin D3.

  1979cited by this paper
• Corticosteroid-induced osteopenia.

  1978cited by this paper
• Hormonal Status in Normal, Osteoporotic and Corticosteroid-Treated Postmenopausal Women 1

  1978cited by this paper
• Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture.

  1976cited by this paper
• Effect of glucocorticoids on function of the parathyroid glands in man.

  1975cited by this paper
• A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture.

  1975cited by this paper
• Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

  1974cited by this paper
• Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.

  1973cited by this paper
• Effect of gonadotrophins on the secretion of oestradiol- and testosterone by the rat testis.

  1973cited by this paper
• Simplified method for the estimation of inorganic phosphorus in body fluids.

  1966cited by this paper
• Determination of serum calcium by means of orthocresolphthalein complexone.

  1966cited by this paper
• BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.

  1965cited by this paper
• EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.

  1964cited by this paper
• New tables for multiple comparisons with a control.

  1964cited by this paper
• Simple and precise micromethod for EDTA titration of calcium.

  1963cited by this paper
• The action of corticosteroids on the renal reabsorption of calcium.

  1960cited by this paper
• Pathological fractures in patients with rheumatoid arthritis treated with cortison.

  1952cited by this paper
• The Roentgenographic Appearance of the Bones in Cushing's Syndrome1

  1942cited by this paper
• THE COLORIMETRIC DETERMINATION OF PHOSPHORUS

  1925cited by this paper

• Geometrical factor, bond order analysis, vibrational energies, electronic properties (gas and solvent phases), topological and molecular docking analysis on Ipriflavone-osteoporosis diseases

  2024cites this paper
• Phoenix dactilyfera L. Pits Extract Restored Bone Homeostasis in Glucocorticoid-Induced Osteoporotic Animal Model through the Antioxidant Effect and Wnt5a Non-Canonical Signaling

  2022cites this paper
• Nutraceuticals for better management of osteoporosis: An overview

  2018cites this paper
• Novel O‐Alkylated Chromones as Antimicrobial Agents: Ultrasound Mediated Synthesis, Molecular Docking and ADME Prediction

  2017cites this paper
• Synthesis, antimicrobial activity and anti-biofilm activity of novel tetrazole derivatives

  2017cites this paper
• Ipriflavone in the Treatment of Postmenopausal Osteoporosis

  2017cites this paper
• Soybean and the Prevention of Chronic Human Disease

  2016cites this paper
• The effect of isoflavones on early bone formation on orthopedically expanded suture in male rats

  2013cites this paper
• Development of Estrogen Antagonists as Pharmaceutical Agents

  2010cites this paper
• Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity.

  2010cites this paper
• Natural and synthetic isoflavones in the prevention and treatment of chronic diseases

  2009cites this paper
• Influence of prednisolone-induced osteoporosis on bone mass and bone quality of the mandible in rats.

  2009cites this paper
• Efficacy of ipriflavone in established osteoporosis and long-term safety

  2009cites this paper
• Design for an ipriflavone multicenter European fracture study

  2009cites this paper
• Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists

  2009cites this paper
• In Vitro and In Vivo effects of ipriflavone on bone formation and bone biomechanics

  2009cites this paper
• Dual effects of daidzein, a soy isoflavone, on catecholamine synthesis and secretion in cultured bovine adrenal medullary cells.

  2007cites this paper
• Effects of 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one (ipriflavone) on serum levels of calcitonin and parathyroid hormone in patients with adult-onset diabetes

  2006influential citation
• Curative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis -- with special reference to bone metabolism.

  2006cites this paper
• Skeletal Effects of Soy Isoflavones in Humans: Bone Mineral Density and Bone Markers

  2006cites this paper
• Effect of ipriflavone on bone mineral content in osteoporotic patients

  2006cites this paper
• Ipriflavone inhibits murine osteoclast formationIn Vitro

  2005cites this paper
• Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells

  2005cites this paper
• Histochemical and fine structural study of bone of ipriflavone-treated rats

  2005cites this paper
• The effect of oral ipriflavone on the rat mandible during growth.

  2005cites this paper
• Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years

  2005cites this paper
• Ipriflavone influences the osteoblastic phenotype in Vitro

  2005cites this paper
• Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females

  2005cites this paper
• A pilot study of antitumor effect of gallium ethylenediaminetetramethylene phosphonate [Ga(III)-EDTMP] in tumor-bearing rats

  2005cites this paper
• Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells

  2005cites this paper
• The Use of Complementary and Alternative Therapies in Older Women

  2003cites this paper
• ECL cell histamine mobilization studied by gastric submucosal microdialysis in awake rats: methodological considerations.

  2003cites this paper
• Effect of Synthetic Oligopeptides on Osteoporosis

  2003cites this paper
• Studies on the synthesis and anti-Osteoporosis of estrogen-GHRPs linkers.

  2003cites this paper
• Prevention of osteopaenia by phyto-oestrogens: animal studies

  2003cites this paper
• Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model

  2002cites this paper
• Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.

  2002cites this paper
• Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial.

  2002cites this paper
• Effects of Siberian Ginseng Extract and Ipriflavone on the Development of Glucocorticoid-Induced Osteoporosis

  2002cites this paper
• EFFECT OF SYNTHETIC OLIGOPEPTIDES ON OSTEOPOROSIS

  2002cites this paper
• Usual Dietary Isoflavone Intake, Bone Mineral Density, and Bone Metabolism in Postmenopausal Women

  2002cites this paper
• Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

  2001cites this paper
• Complementary medicine for prostate cancer: effects of soy and fat consumption.

  2001cites this paper
• Comparison of osteopenia after gastrectomy, ovariectomy and prednisolone treatment in the young female rat

  2001influential citation
• The Synthetic Phytoestrogen, Ipriflavone, and Estrogen Prevent Bone Loss by Different Mechanisms

  2000cites this paper
• Supplemental and complementary alternatives to hormone replacement therapy.

  1999cites this paper
• Flavonoids: old and new aspects of a class of natural therapeutic drugs.

  1999cites this paper
• Phytoestrogens and menopause.

  1999cites this paper
• Ipriflavone: an important bone-building isoflavone.

  1999cites this paper
• Culture of stromal cells derived from medullary cavity of human long bone in the presence of 1,25-dihydroxyvitamin D3, recombinant human bone morphogenetic protein-2, or ipriflavone.

  1998cites this paper
• Effects of Ipriflavone on Perialveolar Bone Formation

  1998cites this paper
• Estimation of the effects of prednisolone on bone metabolism in rats by biochemical markers

  1998cites this paper
• Effects of steroid-induced osteoporosis on osseointegration of titanium implants.

  1998cites this paper
• Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women.

  1997cites this paper
• A Double Blind, Placebo-Controlled Trial of Ipriflavone for Prevention of Postmenopausal Spinal Bone Loss

  1997cites this paper
• Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT.

  1997cites this paper
• Determination of ipriflavone and its synthetic impurities by high-performance liquid chromatography using diode-array detection.

  1996cites this paper
• Ipriflavone does not alter bone apatite crystal structure in adult male rats

  1996cites this paper
• Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone

  1996cites this paper
• Glucocorticoid-induced osteopenia in rats: histomorphometrical and microarchitectural characterization and calcitonin effect.

  1996cites this paper
• Ipriflavone improves bone density and biomechanical properties of adult male rat bones

  1995influential citation
• Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis.

  1995cites this paper
• Recent developments in the chemotherapy of osteoporosis.

  1995cites this paper
• Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass

  1994cites this paper
• Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites

  1994cites this paper
• Ipriflavone directly inhibits osteoclastic activity.

  1994cites this paper
• Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture

  1994cites this paper
• Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone.

  1994cites this paper
• Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists.

  1994cites this paper
• Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women

  1993cites this paper
• Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis.

  1993cites this paper
• [Osteoporosis. Detection, prevention, and treatment].

  1993cites this paper
• Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells

  1993cites this paper
• Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium.

  1993cites this paper
• Ipriflavone: New insights into its mechanisms of action on bone remodeling

  1993cites this paper
• New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs.

  1993cites this paper
• Effects of menatetrenone on prednisolone-induced bone loss in rats.

  1993cites this paper
• Short-term treatment of Paget's disease of bone with ipriflavone.

  1992cites this paper
• Effects of ipriflavone on bone remodeling in primary hyperparathyroidism.

  1992cites this paper
• Ipriflavone inhibits phosphoinositide hydrolysis and Ca2+ uptake in the osteoblast-like UMR-106 cells.

  1992cites this paper
• Flavonoids: biochemical effects and therapeutic applications.

  1992cites this paper
• Effect of swimming on prednisolone‐induced osteoporosis in elderly rats

  1992cites this paper
• Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: preliminary results.

  1992cites this paper
• Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium

  1992cites this paper
• Effect of ipriflavone on bone mass in elderly osteoporotic women.

  1992cites this paper
• Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats

  1992cites this paper
• Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line

  1991cites this paper
• In vivo models in the study of osteopenias.

  1991cites this paper
• Investigations of mineral concentrations, mechanical and biochemical parameters in rat’s hair and bone, and correlations between them

  1991cites this paper
• Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.

  1991cites this paper
• Physiological and pharmacological regulation of biological calcification.

  1991cites this paper
• Bone mineral and matrix. Are they altered in osteoporosis?

  1990cites this paper
• Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.

  1989cites this paper
• Accelerated bone resorption in senescence‐accelerated mouse (SAM‐P/6)

  1989cites this paper
• Suppressive effect of ipriflavone on bone depletion in the experimental diabetic rat: dose response of ipriflavone.

  1988cites this paper
• Effect of ipriflavone on accessory sexual organs and bone metabolism in male rats.

  1987cites this paper
• Chapter 17 Medicinal Chemistry Opportunities in Bone Metabolism and Osteoporosis

  1987cites this paper
• Effect of Ipriflavone (TC-80) on the Calvaria of Neonatal Rats

  1986cites this paper
• Overview of the management of low bone mass and osteoporosis in postmenopausal women

  year unknowncites this paper